Diagnosis typically involves a combination of clinical evaluation, neurological examination, and advanced imaging techniques such as MRI and PET scans. Biomarkers in blood and cerebrospinal fluid are increasingly being used to aid in early diagnosis, particularly for Alzheimer's disease.
